check_circleStudy Completed

Diabetes Mellitus

Bayer Identifier:

14284

ClinicalTrials.gov Identifier:

NCT00909051

EudraCT Number:

Not Available

EU CT Number:

Not Available
GlucoVIP - Diabetes treatment by Glucobay® with a special therapeutic view to chosen patient groups

Trial purpose

Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.

Key Participants Requirements

Sex

Both

Age

18 - N/A


  • - Patients with untreated or pretreated diabetes mellitus or patients for which acarbose is indicated and without acarbose treatment within the last three months before study inclusion. The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.


  • - Exclusion criteria must be read in conjunction with the local product information.

Trial summary

Enrollment Goal
15729
Trial Dates
March 2009 - December 2010
Phase
N/A
Could I Receive a placebo
No
Products
Precose/Glucobay (Acarbose, BAYG5421)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Russia
Completed
Many Locations, China
Completed
Many Locations, Indonesia
Completed
Many Locations, Hong Kong
Completed
Many Locations, Malaysia
Completed
Many Locations, Thailand
Terminated
Many Locations, Moldova
Completed
Many Locations, Korea, Republic Of
Completed
Many Locations, India
Completed
Many Locations, Philippines
Completed
Many Locations, Singapore
Completed
Many Locations, Pakistan
Completed
Many Locations, Cambodia
Completed
Many Locations, Viet Nam
Completed
Many Locations, Bosnia and Herzegovina
Completed
Many Locations, Algeria

Primary Outcome

  • Data collection on patients weight and waist circumference, fasting blood glucose, postprandial blood glucose (2h), HbA1C; exploratory analysis according to patient groups (concomitant cardiovascular disease groups, BMI)
    date_rangeTime Frame:
    During observation period of three months
    enhanced_encryption
    Safety Issue:
    No

Trial design

Diabetes treatment by Glucobay® with a special therapeutic view to chosen patient groups
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.